Cargando…

Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation

Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia. One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble...

Descripción completa

Detalles Bibliográficos
Autores principales: Pooladanda, Venkatesh, Thatikonda, Sowjanya, Bale, Swarna, Pattnaik, Bijay, Sigalapalli, Dilep Kumar, Bathini, Nagendra Babu, Singh, Shashi Bala, Godugu, Chandraiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349848/
https://www.ncbi.nlm.nih.gov/pubmed/30692512
http://dx.doi.org/10.1038/s41419-018-1247-9
_version_ 1783390332500574208
author Pooladanda, Venkatesh
Thatikonda, Sowjanya
Bale, Swarna
Pattnaik, Bijay
Sigalapalli, Dilep Kumar
Bathini, Nagendra Babu
Singh, Shashi Bala
Godugu, Chandraiah
author_facet Pooladanda, Venkatesh
Thatikonda, Sowjanya
Bale, Swarna
Pattnaik, Bijay
Sigalapalli, Dilep Kumar
Bathini, Nagendra Babu
Singh, Shashi Bala
Godugu, Chandraiah
author_sort Pooladanda, Venkatesh
collection PubMed
description Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia. One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble tumor necrosis factor (TNF-α) has a key role, which exerts cytotoxicity in epithelial and endothelial cells thus exacerbates edema. The bacterial lipopolysaccharide (LPS) was used both in vitro (RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B) and in vivo (C57BL/6 mice), as it activates a plethora of overlapping inflammatory signaling pathways involved in ARDS. Nimbolide is a chemical constituent of Azadirachta indica, which contains multiple biological properties, while its role in ARDS is elusive. Herein, we have investigated the protective effects of nimbolide in abrogating the complications associated with ARDS. We showed that nimbolide markedly suppressed the nitrosative-oxidative stress, inflammatory cytokines, and chemokines expression by suppressing iNOS, myeloperoxidase, and nitrotyrosine expression. Moreover, nimbolide mitigated the migration of neutrophils and mast cells whilst normalizing the LPS-induced hypothermia. Also, nimbolide modulated the expression of epigenetic regulators with multiple HDAC inhibitory activity by suppressing the nuclear translocation of NF-κB and HDAC-3. We extended our studies using molecular docking studies, which demonstrated a strong interaction between nimbolide and TNF-α. Additionally, we showed that treatment with nimbolide increased GSH, Nrf-2, SOD-1, and HO-1 protein expression; concomitantly abrogated the LPS-triggered TNF-α, p38 MAPK, mTOR, and GSK-3β protein expression. Collectively, these results indicate that TNF-α-regulated NF-κB and HDAC-3 crosstalk was ameliorated by nimbolide with promising anti-nitrosative, antioxidant, and anti-inflammatory properties in LPS-induced ARDS.
format Online
Article
Text
id pubmed-6349848
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63498482019-01-29 Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation Pooladanda, Venkatesh Thatikonda, Sowjanya Bale, Swarna Pattnaik, Bijay Sigalapalli, Dilep Kumar Bathini, Nagendra Babu Singh, Shashi Bala Godugu, Chandraiah Cell Death Dis Article Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia. One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble tumor necrosis factor (TNF-α) has a key role, which exerts cytotoxicity in epithelial and endothelial cells thus exacerbates edema. The bacterial lipopolysaccharide (LPS) was used both in vitro (RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B) and in vivo (C57BL/6 mice), as it activates a plethora of overlapping inflammatory signaling pathways involved in ARDS. Nimbolide is a chemical constituent of Azadirachta indica, which contains multiple biological properties, while its role in ARDS is elusive. Herein, we have investigated the protective effects of nimbolide in abrogating the complications associated with ARDS. We showed that nimbolide markedly suppressed the nitrosative-oxidative stress, inflammatory cytokines, and chemokines expression by suppressing iNOS, myeloperoxidase, and nitrotyrosine expression. Moreover, nimbolide mitigated the migration of neutrophils and mast cells whilst normalizing the LPS-induced hypothermia. Also, nimbolide modulated the expression of epigenetic regulators with multiple HDAC inhibitory activity by suppressing the nuclear translocation of NF-κB and HDAC-3. We extended our studies using molecular docking studies, which demonstrated a strong interaction between nimbolide and TNF-α. Additionally, we showed that treatment with nimbolide increased GSH, Nrf-2, SOD-1, and HO-1 protein expression; concomitantly abrogated the LPS-triggered TNF-α, p38 MAPK, mTOR, and GSK-3β protein expression. Collectively, these results indicate that TNF-α-regulated NF-κB and HDAC-3 crosstalk was ameliorated by nimbolide with promising anti-nitrosative, antioxidant, and anti-inflammatory properties in LPS-induced ARDS. Nature Publishing Group UK 2019-01-28 /pmc/articles/PMC6349848/ /pubmed/30692512 http://dx.doi.org/10.1038/s41419-018-1247-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Pooladanda, Venkatesh
Thatikonda, Sowjanya
Bale, Swarna
Pattnaik, Bijay
Sigalapalli, Dilep Kumar
Bathini, Nagendra Babu
Singh, Shashi Bala
Godugu, Chandraiah
Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
title Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
title_full Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
title_fullStr Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
title_full_unstemmed Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
title_short Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
title_sort nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting tnf-α mediated nf-κb and hdac-3 nuclear translocation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349848/
https://www.ncbi.nlm.nih.gov/pubmed/30692512
http://dx.doi.org/10.1038/s41419-018-1247-9
work_keys_str_mv AT pooladandavenkatesh nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation
AT thatikondasowjanya nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation
AT baleswarna nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation
AT pattnaikbijay nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation
AT sigalapallidilepkumar nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation
AT bathininagendrababu nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation
AT singhshashibala nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation
AT goduguchandraiah nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation